X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs GSK PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD GSK PHARMA WYETH LTD/
GSK PHARMA
 
P/E (TTM) x 27.7 63.6 43.6% View Chart
P/BV x 5.3 10.2 52.4% View Chart
Dividend Yield % 1.3 1.2 102.8%  

Financials

 WYETH LTD   GSK PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
GSK PHARMA
Mar-17
WYETH LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0443,838 27.2%   
Low Rs8182,637 31.0%   
Sales per share (Unadj.) Rs298.6354.2 84.3%  
Earnings per share (Unadj.) Rs57.239.8 144.0%  
Cash flow per share (Unadj.) Rs58.442.9 136.3%  
Dividends per share (Unadj.) Rs17.0030.00 56.7%  
Dividend yield (eoy) %1.80.9 197.0%  
Book value per share (Unadj.) Rs249.5236.9 105.3%  
Shares outstanding (eoy) m22.7284.70 26.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.19.1 34.1%   
Avg P/E ratio x16.381.4 20.0%  
P/CF ratio (eoy) x15.975.5 21.1%  
Price / Book Value ratio x3.713.7 27.3%  
Dividend payout %29.775.4 39.4%   
Avg Mkt Cap Rs m21,157274,216 7.7%   
No. of employees `0000.54.7 10.5%   
Total wages/salary Rs m4004,830 8.3%   
Avg. sales/employee Rs Th13,787.46,387.0 215.9%   
Avg. wages/employee Rs Th813.01,028.3 79.1%   
Avg. net profit/employee Rs Th2,643.3717.1 368.6%   
INCOME DATA
Net Sales Rs m6,78330,000 22.6%  
Other income Rs m353728 48.4%   
Total revenues Rs m7,13630,728 23.2%   
Gross profit Rs m1,6174,190 38.6%  
Depreciation Rs m27263 10.1%   
Interest Rs m60-   
Profit before tax Rs m1,9384,655 41.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5457 -1.1%   
Tax Rs m6321,744 36.3%   
Profit after tax Rs m1,3013,368 38.6%  
Gross profit margin %23.814.0 170.7%  
Effective tax rate %32.637.5 87.1%   
Net profit margin %19.211.2 170.8%  
BALANCE SHEET DATA
Current assets Rs m6,98416,742 41.7%   
Current liabilities Rs m2,0567,202 28.5%   
Net working cap to sales %72.631.8 228.4%  
Current ratio x3.42.3 146.1%  
Inventory Days Days9952 191.6%  
Debtors Days Days2421 115.2%  
Net fixed assets Rs m2448,635 2.8%   
Share capital Rs m227847 26.8%   
"Free" reserves Rs m5,44119,222 28.3%   
Net worth Rs m5,66820,069 28.2%   
Long term debt Rs m2510 250.0%   
Total assets Rs m7,90130,038 26.3%  
Interest coverage x353.3NM-  
Debt to equity ratio x00 885.2%  
Sales to assets ratio x0.91.0 86.0%   
Return on assets %16.511.2 147.4%  
Return on equity %22.916.8 136.7%  
Return on capital %34.025.5 133.7%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m15528 2.9%   
Fx outflow Rs m2,6777,193 37.2%   
Net fx Rs m-2,662-6,665 39.9%   
CASH FLOW
From Operations Rs m9232,360 39.1%  
From Investments Rs m3173,008 10.5%  
From Financial Activity Rs m-481-5,108 9.4%  
Net Cashflow Rs m759260 291.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 50.7 100.8%  
Indian inst/Mut Fund % 11.3 10.2 110.8%  
FIIs % 7.2 23.8 30.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 15.4 197.4%  
Shareholders   21,978 102,036 21.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ABBOTT INDIA  NATCO PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS